EUVIMEDEUVIMED entdecken
Open Access

Inhibiting Phosphatidylcholine Remodeling in Adipose Tissue Increases Insulin Sensitivity

Mulin He, Zhiqiang Li, Victoria Sook Keng Tung, Meixia Pan, Xianlin Han iD, Oleg Evgrafov, Xian-Cheng Jiang iD

Diabetes · 2023

DOI: 10.2337/db23-0317 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, 2023. Verfasst von Mulin He und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, The State University of New York Downstate Health Sciences University, Brooklyn, NY. Hauptthemen laut MEDLINE: Phosphatidylcholines, Insulin Resistance. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIA NIH HHS, BLRD VA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cell membrane phosphatidylcholine (PC) composition is regulated by lysophosphatidylcholine acyltransferase (LPCAT); changes in membrane PC saturation are implicated in metabolic disorders. Here, we identified LPCAT3 as the major isoform of LPCAT in adipose tissue and created adipocyte-specific Lpcat3–knockout mice to study adipose tissue lipid metabolism. Transcriptome sequencing and plasma adipokine profiling were used to investigate how LPCAT3 regulates adipose tissue insulin signaling. LPCAT3 deficiency reduced polyunsaturated PCs in adipocyte plasma membranes, increasing insulin sensitivity. LPCAT3 deficiency influenced membrane lipid rafts, which activated insulin receptors and AKT in adipose tissue, and attenuated diet-induced insulin resistance. Conversely, higher LPCAT3 activity in adipose tissue from ob/ob, db/db, and high-fat diet–fed mice reduced insulin signaling. Adding polyunsaturated PCs to mature human or mouse adipocytes in vitro worsened insulin signaling. We suggest that targeting LPCAT3 in adipose tissue to manipulate membrane phospholipid saturation is a new strategy to treat insulin resistance. Article Highlights

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhosphatidylcholinesInsulin ResistanceHumansAnimalsMiceAdipose TissuePhospholipidsInsulinMice, Inbred C57BLDiet, High-Fat1-Acylglycerophosphocholine O-Acyltransferase

Substanzen

PhosphatidylcholinesPhospholipidsInsulinLPCAT3 protein, mouse1-Acylglycerophosphocholine O-Acyltransferase

Autor:innen und Institutionen

  • Department of Cell Biology, The State University of New York Downstate Health Sciences University, Brooklyn, NY.
  • Lipidomics Core, The University of Texas Health Science Center at San Antonio, San Antonio, TX.
  • Molecular and Cellular Cardiology Program, Veterans Affairs New York Harbor Healthcare System, New York, NY.

ORCID-Profile: Xianlin Han, Xian-Cheng Jiang

Förderung

  • NHLBI NIH HHS
  • NIA NIH HHS
  • BLRD VA
  • NIH HHS
  • VA
  • NIH

Zitieren

APA

He, M., Li, Z., Tung, V. S. K., Pan, M., Han, X., Evgrafov, O., & Jiang, X. C. (2023). Inhibiting Phosphatidylcholine Remodeling in Adipose Tissue Increases Insulin Sensitivity. Diabetes. https://doi.org/10.2337/db23-0317

Vancouver

He M, Li Z, Tung VSK, Pan M, Han X, Evgrafov O, et al. Inhibiting Phosphatidylcholine Remodeling in Adipose Tissue Increases Insulin Sensitivity. Diabetes. 2023. doi:10.2337/db23-0317

BibTeX
@article{He2023,
  author = {He, Mulin and Li, Zhiqiang and Tung, Victoria Sook Keng and Pan, Meixia and Han, Xianlin and Evgrafov, Oleg and Jiang, Xian-Cheng},
  title = {Inhibiting Phosphatidylcholine Remodeling in Adipose Tissue Increases Insulin Sensitivity},
  journal = {Diabetes},
  year = {2023},
  doi = {10.2337/db23-0317}
}
Kostenlos starten →